RVMD

REVOLUTION MEDICINES INC

Healthcare | Mid Cap

-$0.89

EPS Forecast

$3.9

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2024-12-31
PLXProtalix Biotherapeutics IncVIRVir Biotechnology IncBCRXBiocryst Pharmaceuticals IncRGNXRegenxbio IncRLAYRelay Therapeutics IncVCELVericel Corp